Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00892151
Other study ID # CTD-2009-01
Secondary ID
Status Completed
Phase N/A
First received May 1, 2009
Last updated January 29, 2016
Start date April 2009
Est. completion date April 2009

Study information

Verified date January 2016
Source Ascensia Diabetes Care
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate a Diabetes management program in the hands of potential users, both health care professionals and lay persons.


Description:

Diabetes data management programs upload glucose meter results to computers to provide information at home to lay people with diabetes and their healthcare professionals to manage their diabetes. The study evaluated the subjects' success using the software program with a blood glucose meter to perform specific tasks, such as uploading the meter results, changing program and meter settings, and displaying reports. The study also evaluated the system's ease of use and the acceptability of product labeling.


Recruitment information / eligibility

Status Completed
Enrollment 51
Est. completion date April 2009
Est. primary completion date April 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

Lay users must:

- Be at least 18 years of age (at least 80% must be 55 years or less)

- Have diabetes or be the parent or legal guardian of a child with diabetes who routinely test their blood sugar at home

- Be testing blood sugar at home at least twice daily for at least one month or be the parent or legal guardian of a child who has been testing blood sugar at home at least twice daily for at least one month

- Be able to speak, read, and understand English

- Have experience using PC programs or browsing the internet

- Have utilized diabetes management software at home in the last year (at least 75% of lay users) or be familiar with diabetes management software

HCPs must:

- Have experience using diabetes data management software in the medical office or assist in patients' diabetes disease management using software

Exclusion Criteria:

- Person working for a competitive medical device company

- Person having a cognitive disorder or condition which, in the opinion of the investigator, would put the person at risk or compromise the integrity of the study.

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
GLUCOFACTS® Deluxe
Diabetes Data Management Software

Locations

Country Name City State
United States AMCR Institute Escondido California

Sponsors (1)

Lead Sponsor Collaborator
Ascensia Diabetes Care

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants Rated Successful (<=3) at Performing Specific Tasks Study staff rated participants on their success at perfoming specific tasks. The rating scale was:
= Successful
= Successful after being referred to user instructions
= Successful with verbal assistance or review of part of user instructions (Similar to review of a specific function during a Customer Service call.)
= Unsuccessful (Incorrectly performed part of the testing regimen or required intervention by study staff.)
= Problem encountered with software
1-2 hours No
Secondary Percentage of Participants Who Rated Ease of Performing Specific Tasks As <=3 Subjects rated ease of using the software with respect to specific tasks. The rating scale was:
= Very Simple
= Simple
= Neither Simple nor Difficult
= Difficult
= Very Difficult
1-2 hours No
Secondary Number of Participants Who Rated Clarity and Usefulness of User Instructions as >=3 User instructions included online help, User Guide, and a Quick Reference Guide. Subjects rated their clarity and usefulness and the rating scale was:
= Unacceptable
= Poor
= Good
= Very Good
= Excellent
1-2 hours No
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A